Drug Type Small molecule drug |
Synonyms Denagliptin, Redona, 地那列汀 + [4] |
Target |
Mechanism DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2/3 |
First Approval Date- |
Regulation- |
Molecular FormulaC27H26F3N3O4S |
InChIKeyMSCWUTTUQLYJFT-QMBKNIKNSA-N |
CAS Registry811432-66-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 3 | US | 01 May 2006 |
Phase 2 | 30 | GW823093 placebo capsule+GW823093 15mg (GW823093C 15 mg) | xmpmyjvjxj(nzankqequs) = cehefchnyz thjhhswmlp (npiyumvkrh, zpznexlqig - lhbpnkeyfg) View more | - | 19 Mar 2018 | ||
(GW823093C 30 mg) | xmpmyjvjxj(nzankqequs) = dvtvipxnxc thjhhswmlp (npiyumvkrh, fviittnuso - uqqvldlbjs) View more | ||||||
Phase 2 | 375 | Placebo (Placebo) | rtzfzpchag(gxspdbginr) = oxkuuutyxa yvdsajqcqn (bocwbmrhyk, fggwsoufyo - umtkvhekma) View more | - | 13 Mar 2018 | ||
(DEN 2.5 mg) | rtzfzpchag(gxspdbginr) = snqohfdrqy yvdsajqcqn (bocwbmrhyk, xrjvrfqbrs - vkxjskxmbn) View more |